NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ABACAVIR/LAMIVUDINE 600/300 APOTEX TABLET Contains the active ingredients abacavir (as sulfate) and lamivudine Consumer Medicine Information PATIENTS TAKING ABACAVIR AND LAMIVUDINE COMBINATION TABLETS, WHICH CONTAINS ABACAVIR, MAY…
Read MoreBuvidal Monthly
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BUVIDALĀ® Buprenorphine Consumer Medicine Information Warning: Risk of Serious Harm or Death with Intravenous Administration Serious harm or death could result if administered intravenously. Buvidal Monthly forms…
Read MoreAPO-Amisulpride
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-AMISULPRIDE Amisulpride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about amisulpride. It does not contain all the available information. It…
Read More